Rhodes Melissa

Chief Operating Officer at AVLN

Sold, on record
$371k
Dollars the filings state
Form 4 sales
1
Latest Nov 17, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • AVLNAvalyn Pharma Inc.Chief Operating Officer

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale AVLNRoutine
    Nov 17, 2026 2026

    Sold 13,300 shares at $27.90 ($371k)

    Rhodes Melissa, Chief Operating Officer

    10b5-1 planSold 100% of holdings ($371k position)0 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Rhodes Melissa
Source
Nov 17, 2026Nov 19, 2026AVLNChief Operating OfficerForm 4 sale13,300$371k100.0%RoutineSEC